MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $268,774 | -24.0% | 7,229 | -7.4% | 0.02% | -30.4% |
| Q4 2022 | $353,826 | -26.6% | 7,809 | +13.2% | 0.02% | -25.8% |
| Q3 2022 | $482,000 | -9.1% | 6,898 | -12.7% | 0.03% | +10.7% |
| Q2 2022 | $530,000 | -0.6% | 7,899 | +22.0% | 0.03% | 0.0% |
| Q1 2022 | $533,000 | +133.8% | 6,477 | +316.5% | 0.03% | +100.0% |
| Q4 2021 | $228,000 | -72.7% | 1,555 | -67.0% | 0.01% | -70.2% |
| Q3 2021 | $834,000 | +0.6% | 4,714 | -8.2% | 0.05% | +4.4% |
| Q2 2021 | $829,000 | -20.7% | 5,133 | -15.9% | 0.04% | -25.0% |
| Q1 2021 | $1,045,000 | -27.9% | 6,103 | -7.5% | 0.06% | -42.9% |
| Q4 2020 | $1,449,000 | -58.1% | 6,596 | -68.3% | 0.10% | -6.2% |
| Q3 2020 | $3,456,000 | +1014.8% | 20,812 | +185.1% | 0.11% | +1500.0% |
| Q4 2018 | $310,000 | +19.2% | 7,300 | +32.4% | 0.01% | +40.0% |
| Q3 2018 | $260,000 | – | 5,513 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |